Characteristics and risk factors associated with critical illness in pediatric COVID-19

Grace Fisler1,2, Stephanie M Izard3, Sareen Shah4,5

  • 1Division of Pediatric Critical Care Medicine, Steven and Alexandra Cohen Children's Medical Center of New York, Northwell Health, Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, 269-01 76th Ave, New Hyde Park, NY, 11040, USA. gfisler@northwell.edu.

Annals of Intensive Care
|December 19, 2020
PubMed

Insights

Older children (over 12) with COVID-19 were more likely to need Pediatric Intensive Care Unit (PICU) admission. Elevated C-reactive protein (CRP) and white blood cell (WBC) counts, along with low platelets, indicated organ dysfunction risk.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Neonatal and pediatric health

Background:

  • Limited data exists on factors predicting organ dysfunction in pediatric COVID-19.
  • This study describes critical illness in children with active SARS-CoV-2 infection.
  • It identifies predictors for Pediatric Intensive Care Unit (PICU) admission and organ dysfunction.

Purpose of the Study:

  • To describe the clinical course of critical illness in pediatric patients with COVID-19.
  • To identify factors associated with PICU admission.
  • To identify factors associated with organ dysfunction in pediatric COVID-19 patients.

Main Methods:

  • Retrospective chart review of 77 pediatric patients (1 day to 21 years) with PCR-confirmed SARS-CoV-2.
  • Data collected from two New York City hospitals between February 1 and April 24, 2020.
  • Descriptive statistics and bivariate comparisons were used to analyze hospital course, laboratory results, and outcomes.

Main Results:

  • 39% of patients required PICU admission; 97% survived.
  • Older age (≥12 years) was associated with increased PICU admission (p=0.015).
  • Elevated C-reactive protein (CRP) correlated with PICU admission (p=0.005) and organ dysfunction (p=0.001).
  • Organ dysfunction was linked to elevated admission CRP, white blood cell (WBC) count, and thrombocytopenia (low platelets).

Conclusions:

  • Age over 12 years and initial CRP levels are associated with PICU admission in pediatric COVID-19.
  • Elevated admission CRP, WBC count, and thrombocytopenia predict organ dysfunction.
  • These biomarkers can help identify pediatric patients at risk for critical illness and organ dysfunction.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
134
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
509
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K